【2024最新】菲律賓SIM卡推薦懶人包！菲律賓網卡怎麼買不踩雷？馬尼拉、宿霧、薄荷島上網實測！

BRAFTOVI® (encorafenib) Home Page | 合法藥品大搜索

BRAFTOVI® (encorafenib) Home Page

WhatisBRAFTOVI?BRAFTOVIisaprescriptionmedicineused:incombinationwithamedicinecalledcetuximab,forthetreatmentofadultswithcancerofyour ...

 BRAFTOVI® (encorafenib) Home Page

IMPORTANT SAFETY INFORMATION AND INDICATION

BRAFTOVI (encorafenib) may cause serious side effects, including:

Risk of new skin cancers. BRAFTOVI, when used alone or with cetuximab, may cause skin cancers called cutaneous squamous cell carcinoma or basal cell carcinoma. Talk to your healthcare provider about your risk for these cancers.

Check your skin and tell your healthcare provider right away about any skin changes, including a:

new wart skin sore or reddish bump that bleeds or does not heal change in size or color of a mole

Your healthcare provider should check your skin before treatment with BRAFTOVI, every 2 months during treatment, ...

閱讀更多

BRAFTOVI Encorafenib Binimetinib Colon cancer Trametinib Colon cancer treatment MEKTOVI Dabrafenib binimetinib台灣 Encorafenib Cobimetinib MEKTOVI Trametinib Binimetinib Selumetinib MEK inhibitor BRAFTOVI Colon cancer Colon cancer treatment Dabrafenib colon cancer中文 colon cancer癌症 Colon cancer symptoms Colon cancer staging Colorectal cancer Colorectal cancer risk factor Transverse colon cancer Colon cancer metastasis Colon cancer staging treatment Colon cancer treatment Guideline dabrafenib仿單 dabrafenib中文 trametinib仿單 dabrafenib機轉 dabrafenib副作用 Tafinlar trametinib健保 encorafenib台灣 Cetuximab Panitumumab V600E mektovi package insert mektovi side effects mektovi cost mektovi manufacturer mektovi mechanism of action mektovi pfizer trametinib中文 trametinib機轉 trametinib副作用 Dabrafenib trametinib 吃阿斯匹靈不能吃什麼 吉 發 企業股份有限公司 面試 Pipemidic acid 250mg 寧疤寧價錢 妥膚淨乳膏類固醇 ALLTEC 外觀 sumincon抗組織胺 長春花種子
Patient Information | 合法藥品大搜索
Indications. BRAFTOVI (encorafenib) and MEKTOVI (binimetinib) are prescription medicines used together to treat people with a type of skin cancer called ... Read More
Safety Information | 合法藥品大搜索
BRAFTOVI (braf-TOE-vee) + MEKTOVI (mek-TOE-vee) is a targeted oral combination therapy used to treat people with melanoma that has spread to other parts ... Read More
Patient Support | 合法藥品大搜索
See risks & benefits for BRAFTOVI® (encorafenib) + MEKTOVI® (binimetinib). Find financial & community support information & the text message support ... Read More
How to Take | 合法藥品大搜索
BRAFTOVI + MEKTOVI can harm your unborn baby; Are breastfeeding or plan to breastfeed. Tell your healthcare provider about all the medicines you take, ... Read More
BRAFTOVI® (encorafenib) Home Page | 合法藥品大搜索
What is BRAFTOVI? BRAFTOVI is a prescription medicine used: in combination with a medicine called cetuximab, for the treatment of adults with cancer of your ... Read More
Home | 合法藥品大搜索
BRAFTOVI® (encorafenib) and MEKTOVI® (binimetinib) are kinase inhibitors indicated for use in combination for the treatment of patients with unresectable or ... Read More
Braftovi | 合法藥品大搜索
Overview. Braftovi is a medicine for treating certain cancers when their cells have a mutation (change) in their genes called 'BRAF V600'. Braftovi is used in ... Read More
Braftovi, INN-encorafenib | 合法藥品大搜索
See section 4.8 for how to report adverse reactions. 1. NAME OF THE MEDICINAL PRODUCT. Braftovi 50 mg hard capsules. Braftovi 75 mg hard capsules. 2. Read More
輝瑞Braftovi併用療法獲批轉移性大腸直腸癌整體存活期延長3個月 | 合法藥品大搜索
2020年4月10日 — 美國時間8日，美國食品與藥物管理局(FDA)宣布，批准輝瑞(Pfizer)的Braftovi (encorafenib)與Erbitux (cetuximab)轉移性大腸直腸癌(CRC)併用 ... Read More
相關資訊整理

【惠補軟膠囊】維他命、礦物質缺乏症

藥品名稱:惠補軟膠囊許可證字號:衛署藥輸字第008229號許可證種類:製　劑適應症:維他命、礦物質缺乏症劑型:藥品類別:須由醫師...

【"濟生"血液透析濃縮液 A-188】血液透析。

藥品名稱:"濟生"血液透析濃縮液A-188許可證字號:衛部藥製字第060393號許可證種類:製　劑適應症:血液透析。劑型:藥品類別:限...

【富娜斯膠囊】治療陰道滴蟲感染所起之陰道炎、白帶、阿米巴痢疾、阿米巴肝膿腫及對ＭＥＴＲＯＮＩＤＡＺＯＬＥ具有感受性之厭氣菌所引起之嚴重感染

藥品名稱:富娜斯膠囊許可證字號:衛署藥製字第002914號許可證種類:製　劑適應症:治療陰道滴蟲感染所起之陰道炎、白帶、阿米巴...

【寧安軟膠囊】焦慮狀態、失眠、肌肉痙攣

藥品名稱:寧安軟膠囊許可證字號:衛署藥輸字第013562號許可證種類:製　劑適應症:焦慮狀態、失眠、肌肉痙攣劑型:第四級管制藥...

【安列康膜衣錠 60毫克】ERLEADA適用於治療下列病人：(1) 轉移性的去勢敏感性前列腺癌 (mCSPC)。(2) 非轉移性的去勢抗性前列腺癌 (nmCRPC)。

藥品名稱:安列康膜衣錠60毫克許可證字號:衛部藥輸字第027596號許可證種類:製　劑適應症:ERLEADA適用於治療下列病人：(1)轉移...

【"愛可泰隆"全可利 膜衣錠62.5毫克】治療因先天性心臟病續發WHO Class III 肺動脈高血壓患者。說明：伴隨先天性Systemic-to-pulmonary shunts與Eisenmenger physiology。

藥品名稱:"愛可泰隆"全可利膜衣錠62.5毫克許可證字號:衛部藥輸字第026173號許可證種類:製　劑適應症:治療因先天性心臟病續發...

【富多拉富栓劑７５０公絲】消化器癌（胃癌、結腸癌、直腸癌）肺癌、乳癌等症狀之緩解

藥品名稱:富多拉富栓劑７５０公絲許可證字號:衛署藥輸字第006425號許可證種類:製　劑適應症:消化器癌（胃癌、結腸癌、直腸癌...

【安護膠囊40毫克】治療女性重度(尿失禁頻率每週大於等於14次)應力性尿失禁。

藥品名稱:安護膠囊40毫克許可證字號:衛署藥輸字第024349號許可證種類:製　劑適應症:治療女性重度(尿失禁頻率每週大於等於14...

【日沛樂膜衣錠240毫克】Zelboraf可用於治療BRAF V600突變陽性且無法以手術切除或轉移性的成人黑色素瘤。

藥品名稱:日沛樂膜衣錠240毫克許可證字號:衛署藥輸字第026043號許可證種類:製　劑適應症:Zelboraf可用於治療BRAFV600突變陽...

【安可平注射劑】急性白血病

藥品名稱:安可平注射劑許可證字號:衛署藥輸字第016252號許可證種類:製　劑適應症:急性白血病劑型:藥品類別:限由醫師使用主成...

【拂劼璐錠】前列腺癌的輔助治療

藥品名稱:拂劼璐錠許可證字號:衛署藥輸字第015543號許可證種類:製　劑適應症:前列腺癌的輔助治療劑型:藥品類別:須由醫師處方...